TickerFacts.

Anixa Biosciences Inc (ANIX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2012-10-31, while the company's latest annual report covers the year ended 2025-10-31. Its later filings do not report this line under the concept TickerFacts maps.

$3.9K
Year ended 2012-10-31
$82.3K2010-10-31: $82.3K2011-10-31: $34.1K2012-10-31: $3.9K$3.9K
2010-10-31 Cost of Revenue (USD) 2012-10-31
Period endedCost of RevenueChange YoYSource filing
2012-10-31$3.9K-88.6%2013-01-29, From 2011-11-01
2011-10-31$34.1K-58.6%2013-01-29, From 2010-11-01
2010-10-31$82.3Kn/a2012-01-30, From 2009-11-01